Wegovy before and after 3 months: what the pictures really show

Trial data from the STEP 1 study found participants lost an average of around 15% of body weight over 68 weeks, but the rate of loss varies significantly across that timeline, with earlier months typically showing slower progress.
Most people titrate from 0.25mg up through 0.5mg, 1.0mg and 1.7mg before reaching the 2.4mg maintenance dose; at three months, many are still mid-titration, which directly affects how much change is visible.
Visible change depends on starting weight, diet, activity level, and which dose a person is currently on, two people photographed at 12 weeks can look completely different even on the same medicine.
Wegovy is a once-weekly subcutaneous injection taken alongside reduced-calorie diet and increased physical activity; lifestyle factors are part of the clinical picture, not optional extras.

At the three-month mark, many people taking Wegovy report visible changes in body shape — but before-and-after pictures tell an incomplete story. Clinical trial data shows average weight loss of around 6–9% of body weight by week 12 on semaglutide 2.4mg, though results vary considerably by dose, adherence and individual biology. Wegovy is a prescription-only medicine; a prescriber reviews your full health picture to decide whether it is clinically appropriate for you. The photographs circulating online often skip over what actually drives those changes — and what to do if your own three-month results look different from what you expected.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How to read three-month results honestly, and make the decision that is right for you

Why the three-month point is rarely what the pictures suggest

The images that get shared most widely online tend to be striking. That is partly selection bias: nobody posts a photo that shows a modest change. By twelve weeks, a person on Wegovy may still be on 1.0mg or 1.7mg, doses that are part of the escalation pathway, not the full therapeutic level. The prescriber titrates slowly to protect tolerability, not because the lower doses are ineffective. Progress at this stage is real, but it is building.

The STEP 1 trial, published in the New England Journal of Medicine, reported roughly 15% average weight loss over 68 weeks at 2.4mg. Extracting a 12-week slice from that curve is genuinely difficult, and individual variation around any average is wide. Starting weight matters a great deal: someone beginning at 130kg losing 8% has shed over 10kg, while someone at 90kg losing 8% has lost around 7kg. Both are real results. If you want a sense of what early visible change can look like, our collection of Wegovy before and after pictures at one month shows the kind of modest but genuine progress that often precedes the more dramatic shifts later in treatment.

Our clinical team at nume hears this concern regularly: people who expected to look different by now and are wondering whether the treatment is working. The honest answer is that three months is still early for many people, and the absence of a dramatic picture does not mean the medicine has failed. It often means the dose escalation is doing exactly what it should.

What actually shapes your personal three-month result

Four factors do most of the work. First, the dose you are currently on. Someone who reached 2.4mg maintenance by week eight will have had a different experience from someone who needed a slower titration because of nausea. Second, how consistently you have taken the injection, storing it correctly in the fridge and injecting on the same day each week makes a measurable difference to steady-state exposure. Third, the dietary changes made alongside treatment. Wegovy reduces appetite significantly for most people, but it is not a substitute for eating enough protein and staying hydrated; muscle loss alongside fat loss changes body composition in ways a photograph cannot capture. Fourth, baseline health, people with metabolic conditions, hormonal factors or a longer history of weight cycling can respond differently.

You can read about how timing affects results in more detail on our guide to how long Wegovy takes to work, which covers the full titration arc rather than a single snapshot.

The NHS guidance on weight management injections makes clear that these medicines work alongside lifestyle support, not instead of it. That framing matters when interpreting any before-and-after photograph.

The decision: should you compare your results at three months, or wait?

This is the real question behind the search. If you are three months into treatment and your results look modest compared to images online, you are probably comparing yourself to a curated selection of the best outcomes taken from the full 68-week timeline. That is not a useful comparison.

What is worth comparing is your own trajectory. Most clinical guidance suggests that six months at the highest tolerated dose is a meaningful point for reviewing whether treatment is delivering enough benefit, not three months on a mid-titration dose. Our page covering results at the six-month mark works through that clinical threshold in more detail.

If you are worried that something is wrong (if side effects are preventing you from staying on the medicine, or if you have had no change at all despite being on maintenance dose) that is a conversation for your prescriber, not a forum. Equally, if you are considering starting treatment and are trying to set realistic expectations, a plain-text account of what three months looks like tends to be more useful than photographs.

For those who want to understand the broader results picture (how one month differs from three, and three from six) our overview of Wegovy weight-loss results covers the full timeline. And if you are still deciding whether Wegovy is the right treatment for your circumstances, the Wegovy treatment page covers eligibility and the clinical context in full.

What before-and-after photographs cannot show

Body composition, blood pressure, cholesterol, blood sugar, sleep quality, joint pain, energy. These are the outcomes that clinical trials measure and that prescribers weigh up. They are invisible in a photograph. The STEP 1 trial found significant improvements in cardiovascular risk markers alongside weight loss, and those benefits often accrue before the scale moves dramatically.

There is also no photograph of the experience of feeling full before finishing a meal for the first time in years, or of the anxiety that comes with a slow week. Those things are real too, and they are part of the three-month picture.

Wegovy is a prescription-only medicine, and it is worth speaking to a prescriber rather than calibrating your expectations against social media images. If you would like a clinical assessment, you are welcome to speak to our prescribers about whether Wegovy is appropriate for you. Every consultation at nume is free, reviewed the same day by a named clinician, and comes with no obligation to proceed.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions